November 26, 2019
Takeda Pharmaceutical said on November 23 that its tetravalent dengue vaccine candidate TAK-003 exhibited consistent vaccine efficacy (VE) in a PIII multinational study. The results from the study were presented at the annual meeting of the American Society of Tropical...read more